(VIAV) Viavi Solutions - Overview
Stock: Test Instruments, Monitoring Software, Optical Coatings, Authentication Products
| Risk 5d forecast | |
|---|---|
| Volatility | 48.2% |
| Relative Tail Risk | -22.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.82 |
| Alpha | 99.22 |
| Character TTM | |
|---|---|
| Beta | 0.902 |
| Beta Downside | 1.021 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.19% |
| CAGR/Max DD | 0.81 |
EPS (Earnings per Share)
Revenue
Description: VIAV Viavi Solutions January 13, 2026
Viavi Solutions (NASDAQ: VIAV) delivers test, monitoring and assurance hardware and software for telecom, cloud, enterprise, public-safety and aerospace networks worldwide, operating through two business units: Network and Service Enablement (NSE) and Optical Security & Performance (OSP).
The NSE segment supplies lab- and field-grade instruments, micro-probes and perpetual software licenses that support 5G roll-outs, edge-cloud deployments and AIOps-driven network automation; in FY 2023 the segment generated roughly $720 million in revenue, growing at a 5 % YoY rate despite a softening telecom capex environment.
The OSP segment leverages Viavi’s optical-coating expertise to produce anti-counterfeiting, 3-D sensing and secure-communication components for aerospace, automotive and industrial customers; this market is expanding at a 12 % CAGR through 2028, driven by rising demand for secure optical links in quantum-key-distribution and autonomous-vehicle lidar systems.
Viavi’s strategic partnership with QuNu Labs aims to integrate quantum-security primitives into its network-intelligence portfolio, positioning the company to capture emerging revenue from quantum-safe communications-a sector projected to exceed $4 billion by 2030.
For a data-rich, unbiased view of Viavi’s valuation metrics and scenario analysis, see the detailed report on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -41.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.89 > 1.0 |
| NWC/Revenue: 63.44% < 20% (prev 62.80%; Δ 0.64% < -1%) |
| CFO/TA 0.04 > 3% & CFO 105.1m > Net Income -41.7m |
| Net Debt (564.3m) to EBITDA (90.9m): 6.21 < 3 |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.4m) vs 12m ago -0.62% < -2% |
| Gross Margin: 55.74% > 18% (prev 0.57%; Δ 5517 % > 0.5%) |
| Asset Turnover: 55.24% > 50% (prev 58.37%; Δ -3.13% > 0%) |
| Interest Coverage Ratio: 0.13 > 6 (EBITDA TTM 90.9m / Interest Expense TTM 72.5m) |
Altman Z'' -15.00
| A: 0.28 (Total Current Assets 1.28b - Total Current Liabilities 489.6m) / Total Assets 2.78b |
| B: -25.10 (Retained Earnings -69.73b / Total Assets 2.78b) |
| C: 0.00 (EBIT TTM 9.40m / Avg Total Assets 2.25b) |
| D: -35.93 (Book Value of Equity -69.84b / Total Liabilities 1.94b) |
| Altman-Z'' Score: -117.7 = D |
Beneish M -2.65
| DSRI: 1.10 (Receivables 320.5m/236.7m, Revenue 1.24b/1.01b) |
| GMI: 1.03 (GM 55.74% / 57.15%) |
| AQI: 1.28 (AQ_t 0.46 / AQ_t-1 0.36) |
| SGI: 1.24 (Revenue 1.24b / 1.01b) |
| TATA: -0.05 (NI -41.7m - CFO 105.1m) / TA 2.78b) |
| Beneish M-Score: -2.65 (Cap -4..+1) = A |
What is the price of VIAV shares?
Over the past week, the price has changed by +9.80%, over one month by +49.03%, over three months by +50.20% and over the past year by +115.37%.
Is VIAV a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the VIAV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.1 | -3.1% |
| Analysts Target Price | 26.1 | -3.1% |
| ValueRay Target Price | 28.7 | 6.7% |
VIAV Fundamental Data Overview February 12, 2026
P/S = 4.7108
P/B = 6.795
P/EG = 2.41
Revenue TTM = 1.24b USD
EBIT TTM = 9.40m USD
EBITDA TTM = 90.9m USD
Long Term Debt = 1.22b USD (from longTermDebt, last quarter)
Short Term Debt = 65.0m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 564.3m USD (from netDebt column, last quarter)
Enterprise Value = 6.42b USD (5.86b + Debt 1.33b - CCE 767.4m)
Interest Coverage Ratio = 0.13 (Ebit TTM 9.40m / Interest Expense TTM 72.5m)
EV/FCF = 81.59x (Enterprise Value 6.42b / FCF TTM 78.7m)
FCF Yield = 1.23% (FCF TTM 78.7m / Enterprise Value 6.42b)
FCF Margin = 6.33% (FCF TTM 78.7m / Revenue TTM 1.24b)
Net Margin = -3.35% (Net Income TTM -41.7m / Revenue TTM 1.24b)
Gross Margin = 55.74% ((Revenue TTM 1.24b - Cost of Revenue TTM 550.4m) / Revenue TTM)
Gross Margin QoQ = 55.32% (prev 56.00%)
Tobins Q-Ratio = 2.31 (Enterprise Value 6.42b / Total Assets 2.78b)
Interest Expense / Debt = 3.77% (Interest Expense 50.1m / Debt 1.33b)
Taxrate = 11.22% (4.40m / 39.2m)
NOPAT = 8.34m (EBIT 9.40m * (1 - 11.22%))
Current Ratio = 2.61 (Total Current Assets 1.28b / Total Current Liabilities 489.6m)
Debt / Equity = 1.59 (Debt 1.33b / totalStockholderEquity, last quarter 834.3m)
Debt / EBITDA = 6.21 (Net Debt 564.3m / EBITDA 90.9m)
Debt / FCF = 7.17 (Net Debt 564.3m / FCF TTM 78.7m)
Total Stockholder Equity = 766.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.85% (Net Income -41.7m / Total Assets 2.78b)
RoE = -5.44% (Net Income TTM -41.7m / Total Stockholder Equity 766.8m)
RoCE = 0.47% (EBIT 9.40m / Capital Employed (Equity 766.8m + L.T.Debt 1.22b))
RoIC = 0.52% (NOPAT 8.34m / Invested Capital 1.60b)
WACC = 8.15% (E(5.86b)/V(7.19b) * Re(9.24%) + D(1.33b)/V(7.19b) * Rd(3.77%) * (1-Tc(0.11)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 76.69% ; FCFF base≈79.8m ; Y1≈75.5m ; Y5≈71.5m
Fair Price DCF = 2.90 (EV 1.24b - Net Debt 564.3m = Equity 671.0m / Shares 231.4m; r=8.15% [WACC]; 5y FCF grow -6.98% → 2.90% )
EPS Correlation: -18.10 | EPS CAGR: 0.0% | SUE: 4.0 | # QB: 2
Revenue Correlation: 1.42 | Revenue CAGR: 4.29% | SUE: 0.90 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=+0.078 | Revisions Net=+7 | Analysts=7
EPS current Year (2026-06-30): EPS=0.84 | Chg30d=+0.162 | Revisions Net=+8 | Growth EPS=+77.8% | Growth Revenue=+35.1%
EPS next Year (2027-06-30): EPS=1.01 | Chg30d=+0.174 | Revisions Net=+7 | Growth EPS=+20.5% | Growth Revenue=+10.6%